Baxter International Inc. (NYSE:BAX) went down by -2.32% from its latest closing price compared to the recent 1-year high of $95.19. The company’s stock price has collected -0.81% of loss in the last five trading sessions. Press Release reported on 01/11/21 that Baxter Biopharma Solutions Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine
Is It Worth Investing in Baxter International Inc. (NYSE :BAX) Right Now?
Baxter International Inc. (NYSE:BAX) scored a price-to-earnings ratio above its average ratio, recording 57.18 x from its present earnings ratio. Plus, the 36-month beta value for BAX is at 0.64. Opinions of the stock are interesting as 12 analysts out of 18 who provided ratings for Baxter International Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 5 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $93.71, which is $13.0 above the current price. BAX currently public float of 510.12M and currently shorts hold a 1.31% ratio of that float. Today, the average trading volume of BAX was 3.05M shares.
BAX’s Market Performance
BAX stocks went down by -0.81% for the week, with a monthly jump of 1.77% and a quarterly performance of 1.17%, while its annual performance rate touched -9.86%. The volatility ratio for the week stands at 2.07% while the volatility levels for the past 30 days are set at 1.92% for Baxter International Inc.. The simple moving average for the period of the last 20 days is 0.55% for BAX stocks with a simple moving average of -3.36% for the last 200 days.
Analysts’ Opinion of BAX
Many brokerage firms have already submitted their reports for BAX stocks, with UBS repeating the rating for BAX by listing it as a “Neutral.” The predicted price for BAX in the upcoming period, according to UBS is $85 based on the research report published on January 06th of the current year 2021.
Goldman, on the other hand, stated in their research note that they expect to see BAX reach a price target of $85, previously predicting the price at $96. The rating they have provided for BAX stocks is “Neutral” according to the report published on December 15th, 2020.
Citigroup gave a rating of “Buy” to BAX, setting the target price at $94 in the report published on October 01st of the previous year.
BAX Trading at 1.94% from the 50-Day Moving Average
After a stumble in the market that brought BAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.37% of loss for the given period.
Volatility was left at 1.92%, however, over the last 30 days, the volatility rate increased by 2.07%, as shares surge +1.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.18% upper at present.
During the last 5 trading sessions, BAX fell by -0.81%, which changed the moving average for the period of 200-days by +0.97% in comparison to the 20-day moving average, which settled at $80.18. In addition, Baxter International Inc. saw 0.40% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at BAX starting from Martin Sean, who sale 47,001 shares at the price of $78.67 back on Nov 02. After this action, Martin Sean now owns 39,640 shares of Baxter International Inc., valued at $3,697,794 using the latest closing price.
FORSYTH JOHN D, the Director of Baxter International Inc., sale 310 shares at $83.59 during a trade that took place back on Sep 14, which means that FORSYTH JOHN D is holding 33,969 shares at $25,913 based on the most recent closing price.
Stock Fundamentals for BAX
Current profitability levels for the company are sitting at:
- +16.79 for the present operating margin
- +43.01 for the gross margin
The net margin for Baxter International Inc. stands at +8.81. The total capital return value is set at 15.16, while invested capital returns managed to touch 8.18. Equity return is now at value 11.30, with 4.70 for asset returns.
Based on Baxter International Inc. (BAX), the company’s capital structure generated 75.63 points at debt to equity in total, while total debt to capital is 43.06. Total debt to assets is 32.77, with long-term debt to equity ratio resting at 67.48. Finally, the long-term debt to capital ratio is 38.42.
When we switch over and look at the enterprise to sales, we see a ratio of 4.05, with the company’s debt to enterprise value settled at 0.13. The receivables turnover for the company is 6.13 and the total asset turnover is 0.67. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.32.